프리마켓
로그인 회원가입
WOOF
WOOF
Petco Health and Wellness Co Inc
7월 27일 4:00 PM ET (한국 7/28 05:00)
$2.72
+0.11 ▲ +4.21%

펫코 헬스 앤 웰니스(WOOF) is a Consumer Cyclical sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독
시가총액
$777M
스몰캡
P/E
145.4
고평가 구간
배당수익률
없음
52주 위치
25%
저점 +21% · 고점 -35%
애널리스트
보유
D
Fundamental health
vs. Specialty Retail
수익성 ⓘ
Top 56%
성장 ⓘ
Top 60%
밸류에이션 ⓘ
Top 62%
재무 안정 ⓘ
Top 69%
Index ⓘ RUTP/E ⓘ 145.45EPS (ttm) ⓘ 0.02Insider Own ⓘ 47.73%Shs Outstand ⓘ 247.3MPerf Week ⓘ 0.37%
Market Cap ⓘ 0.78BForward P/E ⓘ 10.95EPS next Y ⓘ 27.02%Insider Trans ⓘ -0.4%Shs Float ⓘ 149.3MPerf Month ⓘ 5.84%
Enterprise Value ⓘ 3.39BPEG ⓘ 0.52EPS next Q ⓘ 0.07Inst Own ⓘ 53.46%Short Float ⓘ 13.21%Perf Quarter ⓘ -7.48%
Income ⓘ 0.01BP/S ⓘ 0.13EPS this Y ⓘ 16.42%Inst Trans ⓘ -0.12%Short Ratio ⓘ 10.12Perf Half Y ⓘ -7.8%
Sales ⓘ 5.96BP/B ⓘ 0.67EPS next 5Y ⓘ 21.23%ROA ⓘ 0.11%Short Interest ⓘ 19.71MPerf YTD ⓘ -3.2%
Book/sh ⓘ 4.05P/C ⓘ 4.62EPS past 3/5Y ⓘ -54.72% -ROE ⓘ 0.49%52W High ⓘ -35.08% ($4.19)Perf Year ⓘ -19.05%
Cash/sh ⓘ 0.59P/FCF ⓘ 5.88Sales past 3/5Y ⓘ -0.41% 3.91%ROIC ⓘ 0.15%52W Low ⓘ 21.43% ($2.24)Perf 3Y ⓘ -66.29%
Dividend Est. ⓘ -EV/EBITDA ⓘ 9.73EPS Y/Y TTM ⓘ 108.54%Gross Margin ⓘ 36.26%Volatility(W/M) ⓘ 3.59% 4.1%Perf 5Y ⓘ -86.83%
Dividend TTM ⓘ -EV/Sales ⓘ 0.57Sales Y/Y TTM ⓘ -1.91%Oper. Margin ⓘ 2.57%ATR (14) ⓘ 0.12Perf 10Y ⓘ -
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 0.29EPS Q/Q ⓘ -27.14%Profit Margin ⓘ 0.09%RSI (14) ⓘ 54.45Recom ⓘ 3.08
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 0.85Sales Q/Q ⓘ 0.22%SMA20 ⓘ 3.45% ($2.63)Beta ⓘ 1.55Target Price ⓘ $3.42
Payout ⓘ -Debt/Eq ⓘ 2.41Earnings ⓘ 2026/6/3SMA50 ⓘ 1.09% ($2.69)Rel Volume ⓘ 0.76Prev Close ⓘ $2.61
Employees ⓘ 29000LT Debt/Eq ⓘ 2.13EPS/Sales Surpr. ⓘ 142.86% 0.65%SMA200 ⓘ -5.57% ($2.88)Avg Volume(3M) ⓘ 1.95MPrice ⓘ $2.72
IPO ⓘ 2021/1/14Option/Short ⓘ Yes/YesTrades ⓘ 6515Volume ⓘ 1,470,972Change ⓘ 4.21%
Quarterly earnings trend SEC filings · USD
24.8
24.11
25.2*
25.5
25.8
25.11
26.1*
26.5
Revenue Net income 최근 분기: 매출 $1.5B (YoY 0%) · 순이익 $-15M (YoY -30%)
* Q4 figures are derived from the annual filing (10-K) · loss-making quarters are underlined in red

📊 Petco Health and Wellness Co Inc (WOOF) Investment Analysis

What kind of company is Petco Health and Wellness Co Inc?

펫코 헬스 앤 웰니스(WOOF) 성장주
Consumer Cyclical · Specialty Retail
Consumer Cyclical Stocks

🐾 Petco is a U.S. omnichannel pet health and wellness specialty retailer that combines the sale of pet supplies with veterinary care. The company operates an extensive network of pet care centers across the United States, featuring a differentiated business model that integrates the sale of pet food and supplies with services such as veterinary hospitals, grooming, and training.

Learn more about Petco Health and Wellness Co Inc →
Market Cap
$0.8B
Approx. KRW 1.1 trillion
⚖️ 0% of Samsung Electronics
Market Cap Rank2832
Employees29,000people
IPO2021/01/14
Current Price$2.72 ≈ 3,726원
📌 RUT · NASD · USA

Key Events

⏰ Upcoming events
🔔 Earnings release
The next release date has not been announced yet.
🎯 Ex-dividend date
No scheduled dividends
📜 Recent events
🔔 Earnings release 2026년 6월 3일 (수) · 장 마감 후 EPS +142.9% 매출 +0.7%
🔔 Earnings release 2026년 3월 11일 (수) · 장 마감 후 EPS +158.2% 매출 +0.2%

Is it profitable?

Financial health caution
Profitability — How efficiently it makes money
Operating Margin
Profit kept from selling products and services (higher is better)
2.6%
✓ 평균
My positionMid-range
Low range Average High range
Specialty Retail Median 3.9% · Bottom 43%
💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수
Net Margin
Share of revenue left after taxes and interest are paid
0.1%
✓ 평균
My positionMid-range
Low range Average High range
Specialty Retail Median 1.3% · Bottom 44%
💡 일반적으로 8% 이상이면 양호, 15% 이상이면 우수
Gross Margin
Profit after subtracting raw-material costs only (signals product competitiveness)
36.3%
✓ 양호
My positionMid-range
Low range Average High range
Specialty Retail Median 32.9% · Top 40%
💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)
ROE
Annual return earned on shareholders' equity (15%+ is strong)
0.5%
✓ 평균
My positionMid-range
Low range Average High range
Consumer Cyclical 소형주 Median 5.2% · Bottom 37%
💡 일반적으로 15% 이상이면 우수 (단, 부채 레버리지 효과 주의)
ROA
Annual earnings relative to total company assets
0.1%
✓ 평균
My positionMid-range
Low range Average High range
Consumer Cyclical 소형주 Median 1.8% · Bottom 39%
💡 일반적으로 5% 이상이면 양호, 10% 이상이면 우수
ROIC
Return generated per dollar invested in the business
0.1%
✓ 평균
My positionMid-range
Low range Average High range
Consumer Cyclical 소형주 Median 2.2% · Bottom 40%
💡 자본비용(보통 8~10%)보다 높으면 가치 창출, 15% 이상이면 우수
Financial health — Debt & liquidity burden
Debt-to-Equity (D/E)
Debt relative to equity (lower is healthier)
2.41
✓ Average
My positionMid-range
Low range Average High range
Specialty Retail Median 1.17
💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)
Current Ratio
Liquid assets available to cover liabilities due within a year
0.85
✓ 부진
My positionBottom 25%
Low range Average High range
Specialty Retail Median 1.33
💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의
Quick Ratio
Liquid assets excluding inventory, available for immediate use
0.29
✓ 위험
💡 1.0 이상이면 안전, 0.5 미만이면 주의
* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Positive Outlook
Price targets, growth, and valuation are favorable
애널리스트 목표가
$3.42
현재가 대비 +25.7%
💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균
예상 PER (Forward)
10.95배
💡 내년 예상 EPS 기준. 현재 PER과 비교해 이익 성장 반영 정도 확인
PEG (성장 반영 밸류)
0.52
저평가
💡 PEG < 1 — 성장 대비 저렴
내년 EPS 예상 성장률
+27.0%
💡 10% 이상이면 견조한 성장, 마이너스는 이익 감소 예상
5년 EPS 예상 연평균
+21.2%
💡 장기 성장 전망. 15% 이상이면 고성장 기업
⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

Average Earnings Performance
Mixed beats and misses
1
예상 상회
0
예상 부합
1
예상 하회
50%
상회 비율
-17.7%
평균 서프라이즈
2026.06.03
하회
실적 $0.02 · 예상 $0.03 -44.0%
2026.03.11
상회
실적 $0.04 · 예상 $0.04 +8.7%
💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Turnaround Expected
Past performance was weak, but the outlook is positive
Declining Growth EPS or revenue is declining — check for structural issues or economic sensitivity
🔮 How much will it grow? (analyst forecasts)
This Year's EPS Outlook
Projected EPS growth rate for this year
+16.4%
양호
My positionMid-range
Low range Average High range
성장주 소형주 Median 16.2% · Top 50%
Next Year's EPS Outlook
Projected EPS growth rate for next year (analyst consensus)
+27.0%
양호
My positionMid-range
Low range Average High range
성장주 소형주 Median 17.5% · Top 27%
5-Year EPS CAGR Outlook
Projected average annual EPS growth over the next 5 years
+21.2%
양호
My positionMid-range
Low range Average High range
성장주 소형주 Median 18.9% · Top 36%
📊 How much has it grown? (actual results)
Past 3-Year EPS
Actual average annual EPS growth over the past 3 years
-54.7%
매우 부진
My positionBottom 5%
Low range Average High range
성장주 소형주 Median 8.7% · Bottom tier
Past 5-Year Revenue
How much revenue grew over the past 5 years
+3.9%
평균
My positionMid-range
Low range Average High range
성장주 소형주 Median 10.4% · Bottom 29%
⚡ Short-term momentum
QoQ Revenue
Revenue change from the previous quarter (short-term momentum)
+0.2%
평균
My positionMid-range
Low range Average High range
성장주 소형주 Median 7.0% · Bottom 26%
* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.
New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -155%p below the market
WOOF -86.8% · S&P 500 +68.4%
Excess return vs. market (price-based, ex-dividends)
5-year basis
vs S&P 500
-155.2%p
Significantly behind the market
vs Consumer Discretionary (XLY)
-108.1%p
Significantly behind the sector average
1-year basis
vs S&P 500
-35.1%p
Significantly behind the market
vs Consumer Discretionary (XLY)
-17.6%p
behind the sector average
Rank among peers
5-year return Bottom 14% Based on 10 peers
1-year return Lower-Mid (lower 34%) Based on 12 peers
Current position within 52-week range
Low (-21.4%p) High (-35.1%p)
Current price is 21.4% above the 52-week low and 35.1% below the 52-week high
Recent risk (last 120 trading days)
Max drawdown
-31.8%
Annualized volatility
65.8%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

  • close
  • BB Upper
  • BB Mid
  • BB Lower
  • Tenkan
  • Kijun
  • Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🟢
Current diagnosis · 2026-07-27
Uptrend zone

Current price $2.72 above the midline ($2.63). Normal upward flow. Inside the Ichimoku cloud (neutral).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🟡
Current diagnosis · 2026-07-27
Neutral zone — weak trend

MACD -0.009 · Signal -0.022 · Hist 0.012. Weak directional bias.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🟢
Current diagnosis · 2026-07-27
Bullish zone

RSI 54.4 (above the neutral level of 50). Buying pressure leads, supporting a steady rise. Stoch %K is also 78.6.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry
Cheap on Vs. Assets·Vs. Sales·Vs. Cash Flow, In line with peers on Vs. Earnings
💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.
💵 Vs. Earnings Mid-range
🏢 Vs. Assets Cheap
🧾 Vs. Sales Cheap
💧 Vs. Cash Flow Cheap
💵 Vs. Earnings
PER Price-to-Earnings Ratio
How expensive the price is vs. earnings — lower is cheaper
145.45x
✓ Very pricey
My positionBottom 5%
Low range Average High range
Specialty Retail median 18.70x · Bottom 1% — expensive within the industry
💡 PER 15 이하 저평가, 25 이상이면 성장성 검증 필요 (적자 기업은 의미 없음)
💵 Vs. Earnings
Forward PER Forward Price-to-Earnings Ratio
PER using next year's estimated earnings — reflects growth
10.95x
✓ Cheap
My positionMid-range
Low range Average High range
Specialty Retail median 14.63x · Around the industry average
💡 향후 12개월 예상 EPS 기준 PER. 현재 PER보다 낮으면 이익 성장 중
🏢 Vs. Assets
PBR Price-to-Book Ratio
Price vs. the company's asset value — below 1 trades cheaper than assets
0.67x
✓ Very cheap
My positionTop 25%
Low range Average High range
Specialty Retail median 2.68x · Top 15% — relatively cheap within the industry
💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)
🧾 Vs. Sales
PSR Price-to-Sales Ratio
Market cap vs. revenue — lower is cheaper relative to sales
0.13x
✓ Very cheap
My positionTop 25%
Low range Average High range
Specialty Retail median 0.55x · Top 13% — relatively cheap within the industry
💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)
💧 Vs. Cash Flow
EV/EBITDA Enterprise Value Multiple
Total enterprise value ÷ operating cash earnings — a benchmark for M&A
9.73x
✓ Cheap
My positionMid-range
Low range Average High range
Specialty Retail median 11.93x · Around the industry average
💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)
💧 Vs. Cash Flow
P/FCF Price-to-Free-Cash-Flow Ratio
Price vs. actual cash generation — lower means more efficient
5.88x
✓ Cheap
My positionTop 25%
Low range Average High range
Specialty Retail median 14.75x · Top 25% — relatively cheap within the industry
💡 P/FCF 20 이하면 현금창출 대비 저평가 (실질 수익성 기준)
Analyst target price (reference)
$3.42 vs. current price +25.7%
* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.
As of: Recent snapshot · Peer group: Specialty Retail

Who owns it?

Ownership backdrop is unfavorable
Insider modest net selling -0.4% · Institutional modest net selling -0.1% · Short interest elevated 13.2% · Short interest up +2.0pp over last 90d
📈 Recent trading flow (6 months)
🧑‍💼 Insiders (executives & directors)
-0.4%
Insiders net selling
🏦 Institutions (funds & investors)
-0.1%
Institutions net selling
💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.
👥 Holdings composition
🏦 Institutions 53.5%
Adequate institutional weight
Consumer Cyclical 소형주 Median 79.7%
🧑‍💼 Insiders 47.7%
Founder/management large holders (strong skin-in-the-game)
Consumer Cyclical 소형주 Median 11.5%
👤 Retail investors (estimated) 0.0%
Everyone excluding institutions and insiders
Institutions Insiders Retail (est.)
📉 Short-selling metrics
Short ratio
13.2%
Somewhat high
Consumer Cyclical 소형주 Median 9.1%
Past 90 days 📈 +2.0%p increase
Short interest days to cover
10.1 days
Days needed to close short positions using average trading volume
🧮 Share count
Total shares outstanding 247.3M주
Float (tradable shares) 149.3M주
* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

ETFs holding WOOF

ETFs with the highest weightings · 10 total shown
PAWZ
PAWZ
ProShares Pet Care ETF
2.21%
$32M
MYHE
MYHE
State Street My2031 High Yield Corporate Bond ETF
0.59%
$5M
HYDB
HYDB
iShares High Yield Systematic Bond ETF
0.43%
$1.6B
HYBL
HYBL
State Street Blackstone High Income ETF
0.41%
$569M
JPSV
JPSV
JPMorgan Active Small Cap Value ETF
0.34%
$28M
* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)
Sorted by market cap, largest first
StockMarket CapPERPBRROEDividend YieldChange
WOOF WOOF This Stock
$776.7M145.4 ▼0.7 ▲0.49% ▼- +4.2%
AMZN
$2.49T27.6 ▼5.6 ▼24.28% ▲- -0.3%
TSLA
$1.22T287.3 ▼14.1 ▼4.64% ▼- -1.2%
HD
$335.1B23.9 ▼24.1 ▼128.38% ▲2.76% ▲+0.9%
BABA
$275.7B18.6 ▲1.7 ▲10.16% ▲0.9% ▼+2.5%
TM
$193.8B9.3 ▲0.9 ▲10.39% ▲3.56% ▲+2.7%
Sector Avg-21.01.85.62%2.19%-
📊
See the market at a glance with a real-time dashboard Track premarket, regular, and after-hours quotes, screeners, and heatmaps on a single screen
→

Related News & Content

📖 Company overview
펫코 헬스 앤 웰니스(WOOF) 뭐하는 회사일까? - 주가 전망·실적·시총·관련주·본사 총정리
펫코 헬스 앤 웰니스(티커 WOOF)는 반려동물 용품 판매와 동물병원 수의 진료를 결합한 미국의 옴니채널 반려동물 전문 소매 기업으로, 사료·용품 매출과 서비스 부문 실적 개선, 그리고 주가·관련주 흐름이 함께 주목받는 종목입니다.
📚 Related Investment Guides
미국주식 세금 총정리 2026 — 초보자를 위한 계산법과 절세 전략
2026년 미국주식 세금 총정리. 양도소득세 22% 계산법, 배당세 15% 원천징수, 손익통산, 절세 전략까지. 실제 금액 시뮬레이션과 세금 계산기로 내 세금을 직접 확인해보세요.

FAQ

What kind of company is 펫코 헬스 앤 웰니스(WOOF)?

펫코 헬스 앤 웰니스(WOOF) belongs to the Consumer Cyclical sector and operates in the Specialty Retail industry.

What is the market cap of WOOF?

The market cap of WOOF is approximately $777M, ranking 2,832 within its sector.

What is the P/E ratio of WOOF?

WOOF has a P/E ratio of approximately 145.4x, which can be used to assess its valuation relative to the Consumer Cyclical sector average.

What is the 52-week high and low for WOOF?

WOOF has recorded a 52-week high of $4.19 and a low of $2.24.

시황 · 실적발표 · 매수매도 신호, 가장 먼저 받아보세요 🔔 구독

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.